847672-84-8Relevant articles and documents
Click Variations on the Synthesis of 2-Nitrophenyl-4-aryl-1,2,3-triazoles without Isolation of 2-Nitrophenyl Azides
Cisnetti, Federico,Roux, Amélie
supporting information, p. 610 - 614 (2020/03/27)
We report a series of efficient procedures to prepare 2-nitrophenyl-4-aryl-1,2,3-triazoles avoiding the isolation of potentially hazardous 2-nitrophenyl azides. An organocatalyzed azide-enolate variant allows efficient access to the target compounds while
Click 1,2,3-triazole derived fluorescent scaffold by mesoionic carbene-nitrene cyclization: an experimental and theoretical study
Bouchemella, Khadidja,Fauché, Kévin,Anak, Barkahem,Jouffret, Laurent,Bencharif, Mustapha,Cisnetti, Federico
, p. 18969 - 18978 (2018/11/26)
We describe a set of three fluorescent mesoionic benzo[4,5]imidazo-3-ide-[1,2-c]-2-alkyl-1,2,3-triazol-2-ium compounds obtained through a simple, concise and efficient synthetic sequence featuring a copper-catalyzed carbene-nitrene cyclization. The compou
FACTOR XA INHIBITORS
-
Page/Page column 82, (2008/12/07)
The present invention is directed to compounds represented by Formula (I) or a pharmaceutically acceptable salt, ester, or prodrug thereof which are inhibitors of Factor Xa. The present invention is also directed to intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat certain conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.